Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study for Investigating the Effect of Caffeine Consumption on Protein Biomarkers Related to Cardiovascular Disease

NCT06359197 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06359197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study for Investigating the Effect of Caffeine Consumption on Protein Biomarkers Related to Cardiovascular Disease
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 1
Overall status
Unknown status
Start date
April 8, 2024
Completion date
June 1, 2025
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy